Search Thermo Fisher Scientific
Aid in clinical decision making with B·R·A·H·M·S MR-proADM Assay
MR-proADM is a marker of endothelial dysfunction that can be utilized alongside clinical evaluation and other laboratory findings to aid in care decisions for patients with conditions such as infections, sepsis, and heart failure.
Key benefits of the B·R·A·H·M·S MR-proADM Assay include:
- Early assessment of infection severity
- Clinically proven cut-off values
- Accurate prediction of disease progression
- Independence from the etiology of the infection
B·R·A·H·M·S MR-proADM Assay solutions and resources
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S MR-proADM is a registered trademark of B·R·A·H·M·S GmbH.
Nobel Prize is a registered trademark of the Nobel Foundation. Other product names in this document are used for identification purposes; they may be trademarks and/or registered trademarks of their respective companies.
TRACE and KRYPTOR are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific.
View patents and patent marking.